Enzyme Therapy: Current Challenges and Future Perspectives.

Area of Science:

• Biotechnology
• Enzyme Therapeutics
• Immunology

Background:

• Enzymes are increasingly utilized as therapeutic agents for diverse pathologies, including metabolic disorders, cancer, and cardiovascular diseases.
• Enzyme-based treatments offer high specificity and affinity, presenting advantages over conventional therapies.
• Key challenges include short in vivo half-life, lack of targeted delivery, and potential patient immune system reactions.

Observation:

• Monitoring the immune response against therapeutic enzymes is essential for patient safety and treatment efficacy.
• Conventional methods like ELISA can detect immune responses, but newer high-throughput techniques are emerging.
• Microarray assays offer a simple, high-capacity platform for monitoring patient immune responses during enzyme therapies.

Findings:

• Enzyme therapies show promise for conditions like fibrosis, ocular diseases, joint problems, cancer, and cardiovascular diseases.
• The specificity and affinity of enzymes are key advantages for therapeutic applications.
• Immune reactions against enzymes necessitate robust monitoring strategies.

Implications:

• Developing effective strategies to manage or predict immune responses is critical for advancing enzyme therapeutics.
• Microarrays represent a promising tool for real-time monitoring of immune responses in patients undergoing enzyme therapy.
• Ongoing research, including studies on angiotensin-converting enzyme 2 (ACE2) for COVID-19, highlights the evolving potential of enzyme-based treatments.